je.st
news
Tag: merck
Study of Merck melanoma drug halted after survival prolonged
2015-03-24 18:27:10| Biotech - Topix.net
Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients with advanced melanoma. REUTERS: Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients with advanced melanoma.
Tags: study
drug
survival
prolonged
Merck: Why Is Sigma-Aldrich's Deal With Roche Positive For Investors?
2015-03-20 21:52:56| Industrial Machines - Topix.net
The deal is positive for Germany's Merck, the pharma-major that's set to acquire Sigma-Aldrich in mid-2015. Germany's Merck is set to acquire Sigma-Aldrich , a leading global supplier of various chemicals, biochemicals and equipments in the life sciences market, via a deal worth $17 billion.
Tags: positive
deal
investors
roche
Merck KGaA's deputy chief Oschmann set to become CEO: Manager Magazin
2015-03-20 15:28:31| Biotech - Topix.net
Germany's Merck KGaA will promote its deputy chief executive, Stefan Oschmann, to the top job next year to replace Karl-Ludwig Kley, Manager Magazin reported on Friday, citing company sources. FRANKFURT: Germany's Merck KGaA will promote its deputy chief executive, Stefan Oschmann, to the top job next year to replace Karl-Ludwig Kley, Manager Magazin reported on Friday, citing company sources.
Merck Provides Regulatory Update on Investigational Medicine Sugammadex Injection
2015-03-13 21:02:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, said it was informed today that the U.S. Food and Drug Administration (FDA) has cancelled the meeting of the Anesthetic and Analgesic Drug Products Advisory Committee scheduled for March 18, 2015. The committee had planned to discuss the resubmission of the New Drug Application (NDA) for sugammadex injection, Mercks investigational medicine for the reversal of neuromuscular blockade induced by rocuronium or vecuronium. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: update
medicine
regulatory
injection
Merck cancer drug is first approved under UK early access scheme
2015-03-11 18:18:18| Biotech - Topix.net
Merck & Co's cancer drug Keytruda, which works by boosting the immune system but has yet to be licensed in Europe, is the first medicine to be made available to patients in Britain under a new early access scheme. The Medicines and Healthcare Products Regulatory Agency said on Wednesday that the treatment had been cleared to treat adults and children from 12 years of age with advanced melanoma, the deadliest form of skin cancer, after other drugs had failed.
Tags: access
early
approved
drug
Sites : [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] next »